191 related articles for article (PubMed ID: 32714986)
1. Potential of Using Cell-Free DNA and miRNA in Breast Milk to Screen Early Breast Cancer.
Song Q; Zhang Y; Liu H; Du Y
Biomed Res Int; 2020; 2020():8126176. PubMed ID: 32714986
[TBL] [Abstract][Full Text] [Related]
2. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
[TBL] [Abstract][Full Text] [Related]
3. A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection.
Bortul M; Giudici F; Tierno D; Generali D; Scomersi S; Grassi G; Bottin C; Cappelletti MR; Zanconati F; Scaggiante B
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239866
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
Barbirou M; Miller AA; Gafni E; Mezlini A; Zidi A; Boley N; Tonellato PJ
Sci Rep; 2022 May; 12(1):8458. PubMed ID: 35589867
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer.
Liu J; Zhao H; Huang Y; Xu S; Zhou Y; Zhang W; Li J; Ming Y; Wang X; Zhao S; Li K; Dong X; Ma Y; Qian T; Chen X; Xing Z; Zhang Y; Chen H; Liu Z; Pang D; Zhou M; Wu Z; Wang X; Wang X; Wu N; Su J
Mol Cancer; 2021 Feb; 20(1):36. PubMed ID: 33608029
[TBL] [Abstract][Full Text] [Related]
6. PUM1 and RNase P genes as potential cell-free DNA markers in breast cancer.
Murillo Carrasco A; Acosta O; Ponce J; Cotrina J; Aguilar A; Araujo J; Rebaza P; Pinto JA; Fujita R; Buleje J
J Clin Lab Anal; 2021 Apr; 35(4):e23720. PubMed ID: 33522650
[TBL] [Abstract][Full Text] [Related]
7. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study.
Alborelli I; Generali D; Jermann P; Cappelletti MR; Ferrero G; Scaggiante B; Bortul M; Zanconati F; Nicolet S; Haegele J; Bubendorf L; Aceto N; Scaltriti M; Mucci G; Quagliata L; Novelli G
Cell Death Dis; 2019 Jul; 10(7):534. PubMed ID: 31296838
[TBL] [Abstract][Full Text] [Related]
8. Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer.
Moss J; Zick A; Grinshpun A; Carmon E; Maoz M; Ochana BL; Abraham O; Arieli O; Germansky L; Meir K; Glaser B; Shemer R; Uziely B; Dor Y
Ann Oncol; 2020 Mar; 31(3):395-403. PubMed ID: 32067681
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study.
Douvdevani A; Bernstein-Molho R; Asraf K; Doolman R; Laitman Y; Friedman E
Cancer Biomark; 2020; 28(3):269-273. PubMed ID: 32280079
[TBL] [Abstract][Full Text] [Related]
10. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
[TBL] [Abstract][Full Text] [Related]
11. Early-Stage Breast Cancer Detection in Breast Milk.
Saura C; Ortiz C; Matito J; Arenas EJ; Suñol A; Martín Á; Córdoba O; Martínez-Sabadell A; García-Ruiz I; Miranda I; Morales-Comas C; Carrasco E; Viaplana C; Peg V; Nuciforo P; Bayó-Puxan N; Gonzalez-Medina A; Miquel JM; Gómez-Rey M; Villacampa G; Arévalo S; Espinosa-Bravo M; Balmaña J; Dienstmann R; Arribas J; Tabernero J; Vivancos A; Sansó M
Cancer Discov; 2023 Oct; 13(10):2180-2191. PubMed ID: 37704212
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines.
Wang W; Kong P; Ma G; Li L; Zhu J; Xia T; Xie H; Zhou W; Wang S
Oncotarget; 2017 Jun; 8(26):43180-43191. PubMed ID: 28574818
[TBL] [Abstract][Full Text] [Related]
13. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
14. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
15. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
16. Mutation profiling in the PIK3CA, TP53, and CDKN2A genes in circulating free DNA and impalpable breast lesions.
Delmonico L; Costa MASM; Fournier MV; Romano SO; Nascimento CMD; Barbosa AS; Moreira ADS; Scherrer LR; Ornellas MHF; Alves G
Ann Diagn Pathol; 2019 Apr; 39():30-35. PubMed ID: 30634138
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
[No Abstract] [Full Text] [Related]
18. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
19. Identification of Somatic Mutations in Thirty-year-old Serum Cell-free DNA From Patients With Breast Cancer: A Feasibility Study.
Ritter M; Paradiso V; Widmer P; Garofoli A; Quagliata L; Eppenberger-Castori S; Soysal SD; Muenst S; Ng CKY; Piscuoglio S; Weber W; Weber WP
Clin Breast Cancer; 2020 Oct; 20(5):413-421.e1. PubMed ID: 32650988
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cell-free DNA as a diagnostic biomarker in breast cancer patients.
Khurram I; Khan MU; Ibrahim S; Saleem A; Khan Z; Mubeen M; Khawar A; Ali Q
Sci Rep; 2023 Sep; 13(1):15347. PubMed ID: 37715016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]